Form D · Biotechnology

Edwards Lifesciences Corp

Irvine, CA · CIK 0001099800

Offering snapshot reported Jun 1, 2018 · SEC filing

Reported sold
$34.9M
Offering amount: $34.9M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 25, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 1, 2018Initial$34,869,330No comparison25SEC filing
Feb 8, 2017Initial$272,371,872No comparison25SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-313687

Source: Form D, filed Jun 1, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Donald E. Bobo, Jr. Executive
John T. Cardis Director
Kieran T. Gallahue Director
Leslie S. Heisz Director
Jean Luc Lemercier Executive
William J. Link Director
Steven R. Loranger Director
Martha H. Marsh Director
Michael A. Mussallem Director, Executive
Catherine M. Szyman Executive
Scott B. Ullem Executive
Nicholas J. Valeriani Director
Patrick B. Verguet Executive
Wesley W. Von Schack Director
Huimin Wang Executive
Larry L. Wood Executive
Bernard J. Zovighian Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
One Edwards Way
Irvine, CA, 92614